Research graph
References from Biphasic Modulation of Absence Seizures by Lisuride in GAERS: Dissecting the Role of 5-HT2A Receptors. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/nrn811
10.1038/nrn811 · External reference
10.1093/brain/awaa072
10.1093/brain/awaa072 · External reference
10.1016/j.jneumeth.2015.05.022
10.1016/j.jneumeth.2015.05.022 · External reference
10.1124/pr.118.015552
10.1124/pr.118.015552 · External reference
Thalamic distribution and effects of 5-HT2C receptors on tonic GABAA inhibition and absence seizures: implications for treatment
10.3389/fphar.2026.1729460 · 2026 · External reference
Monoamine modulation of tonic GABAA inhibition
2014 · External reference
10.1038/nm.2058
10.1038/nm.2058 · External reference
Developmental and cell type-specific contributions of thalamic serotonin 2A receptors to absence seizures
10.1002/epi.70272 · 2026 · External reference
Unresolved reference
External reference
10.1016/j.neuropharm.2026.111073
10.1016/j.neuropharm.2026.111073 · External reference
10.1007/s002130050585
10.1007/s002130050585 · External reference
10.1016/j.ejphar.2008.07.040
10.1016/j.ejphar.2008.07.040 · External reference
10.1074/mcp.m113.036558
10.1074/mcp.m113.036558 · External reference
Comparative Pharmacological Effects of Lisuride and Lysergic Acid Diethylamide Revisited
10.1021/acsptsci.3c00192 · 2024 · External reference
Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential
10.1038/s41467-023-44016-1 · 2023 · External reference
Dual activation by lisuride of central serotonin 5-HT(1A) and dopamine D(2) receptor sites: drug discrimination and receptor binding studies
1991 · External reference
10.1016/j.jneumeth.2015.09.007
10.1016/j.jneumeth.2015.09.007 · External reference
10.1523/jneurosci.3362-05.2005
10.1523/jneurosci.3362-05.2005 · External reference
10.1016/j.neuropharm.2016.04.016
10.1016/j.neuropharm.2016.04.016 · External reference
10.1016/0028-3908(88)90043-3
10.1016/0028-3908(88)90043-3 · External reference
10.1016/b978-0-444-89710-7.50047-1
10.1016/b978-0-444-89710-7.50047-1 · External reference
Patterns of exploration in rats distinguish lisuride from lysergic acid diethylamide
10.1016/0091-3057(85)90022-x · 1985 · External reference
10.1007/bf00429666
10.1007/bf00429666 · External reference
Evidence that 5□HT2A receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non□psychedelic drugs
10.1111/bph.70109 · 2026 · External reference
10.1016/j.expneurol.2013.03.023
10.1016/j.expneurol.2013.03.023 · External reference
10.1016/s0079-6123(08)00903-5
10.1016/s0079-6123(08)00903-5 · External reference
Prolongation of absence seizures and changes in serotonergic and dopaminergic neurotransmission by nigrostriatal pathway degeneration in genetic absence epilepsy rats
10.1016/j.pbb.2021.173317 · 2022 · External reference
10.1038/s41593-018-0130-4
10.1038/s41593-018-0130-4 · External reference
10.1016/j.pneurobio.2025.102774
10.1016/j.pneurobio.2025.102774 · External reference
10.1152/jn.00650.2001
10.1152/jn.00650.2001 · External reference
10.1016/j.neuroscience.2010.08.043
10.1016/j.neuroscience.2010.08.043 · External reference
10.1016/j.neuron.2007.01.008
10.1016/j.neuron.2007.01.008 · External reference
Are the LSD-analogs lisuride and ergotamine examples of non-hallucinogenic serotonin 5-HT2A receptor agonists?
10.1177/02698811251330741 · 2025 · External reference
